Sermorelin + Ipamorelin blend calculator
A two-peptide blend vial: sermorelin and ipamorelin. Amounts per vial differ by seller. Work out how much of each peptide is in one draw, from the dose of one peptide or from the units you draw.
- Sermorelin250 mcg50%
- Ipamorelin250 mcg50%
- Vial total
- 10 mg
- Total mg/mL
- 5
- Draws per vial
- 20
Sermorelin + Ipamorelin: 10 units (0.1 mL) from a 10 mg vial + 2 mL water = 250 mcg Sermorelin, 250 mcg Ipamorelin.
How the blend math works
Each peptide has its own concentration: its milligrams divided by the water you add. Whatever volume you draw, every peptide comes along in proportion. Dosing by one peptide sets the volume, and that volume sets the dose of all the others.
What is in a Sermorelin + Ipamorelin vial
| Peptide | Amount per vial |
|---|---|
| Sermorelin | Amounts differ by seller; check your vial label |
| Ipamorelin | Amounts differ by seller; check your vial label |
The two ingredients act through different receptors
Sermorelin is a 29 amino acid analogue of human growth hormone-releasing hormone (GHRH), described as the shortest synthetic peptide with full biological activity of GHRH.[3]
Ipamorelin's phase 2 trial describes it as a ghrelin-receptor agonist.[4]
In human volunteers ipamorelin produced a single episode of growth hormone release that peaked at 0.67 hours and declined to negligible levels.[5]
The nearest human data pairs sermorelin with other peptides, not ipamorelin
A retrospective chart review of men on testosterone therapy looked at sermorelin together with GHRP-2 and GHRP-6; IGF-1 averaged 239.0 ng/mL afterwards versus 159.5 at baseline.[6]
The authors conclude that GHRP/SERM therapy raised serum IGF-1 with strict compliance to thrice-daily dosing.[6]
A PubMed title/abstract search for ipamorelin with sermorelin returned 5 records on 2 Oct 2026, and 0 are classed as a study of the pair.
Calculated from pubmed query (ipamorelin[tiab]) AND (sermorelin[tiab] OR Geref[tiab]); search date 2026-10-02; records returned 5; records classed as study of the pair 0. Formula: Counts copied from the combinations dataset (key ipamorelin__sermorelin); no arithmetic applied.
Approval and safety text for the two ingredients
Sermorelin's only FDA record is a discontinued product, so no current label supplies interaction text.[7]
FDA's note cites a published study that reported serious adverse events including death when ipamorelin was given intravenously for gastric motility, and says it has not identified safety information for certain other injectable routes.[8]
WADA's prohibited list names sermorelin among GHRH analogues and ipamorelin among growth hormone secretagogues.[9]
Common questions
How many units of Sermorelin + Ipamorelin for 250 mcg of Sermorelin?
In an example 10 mg Sermorelin + Ipamorelin vial (5 mg Sermorelin, 5 mg Ipamorelin) mixed with 2 mL of water, Sermorelin is at 2.5 mg/mL, so 250 mcg is 10 units (0.10 mL) on a U-100 syringe. That same draw also contains 250 mcg Ipamorelin.
How much of each peptide is in 10 units of Sermorelin + Ipamorelin?
10 units on a U-100 syringe is 0.10 mL. From an example 10 mg Sermorelin + Ipamorelin vial (5 mg Sermorelin, 5 mg Ipamorelin) with 2 mL of water, that draw holds 250 mcg Sermorelin, 250 mcg Ipamorelin.
Is sermorelin with ipamorelin a studied combination?
No. The combinations dataset found 5 records mentioning both and none classed as a study of the pair.
Calculated from records returned 5; records classed as study of the pair 0. Formula: Counts copied from the combinations dataset (key ipamorelin__sermorelin).
How do sermorelin and ipamorelin differ?
Sermorelin is a GHRH analogue while ipamorelin is a ghrelin-receptor agonist.[4]
Is sermorelin still sold as an FDA-approved drug?
No. Drugs@FDA lists only a discontinued sermorelin product.[7]
The peptides in Sermorelin + Ipamorelin
Sources
- 1Metric (SI) Prefixes (NIST Reference on Constants, Units, and Uncertainty)National Institute of Standards and Technology (NIST) · 2025physics.nist.govAccessed 2 Oct 2026
- 2BASAGLAR (insulin glargine) injection, prescribing information (DailyMed)U.S. Food and Drug Administration / DailyMed (Eli Lilly and Company label) · 2026dailymed.nlm.nih.govAccessed 2 Oct 2026
- 3Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 1999PMID 18031173Accessed 2 Oct 2026
- 4Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients.International journal of colorectal disease · 2014PMID 25331030Accessed 2 Oct 2026
- 5Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers.Pharmaceutical research · 1999PMID 10496658Accessed 2 Oct 2026
- 6Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels.American journal of men's health · 2017PMID 28830317Accessed 2 Oct 2026
- 7Drugs@FDA (openFDA) search: active ingredient "sermorelin"U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
- 8Official web pageOfficial web page · web page
- 9World Anti-Doping Code International Standard Prohibited List 2026 (in effect 1 January 2026)World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
Found an error? Report a correction.